REG - PureTech Health PLC - PDMR Notification RSU Vesting
Peel Hunt Reaffirms Their Buy Rating on PureTech Health (PRTC)
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
PureTech Health (LON:PRTC) Shares Down 9.2% - Time to Sell?
PureTech Health Balances Clinical Wins With Cash Demands
PureTech Health (NASDAQ:PRTC) Posts Quarterly Earnings Results, Beats Estimates By $0.59 EPS